Success Stories

Präzise Diagnostik mit künstlicher Intelligenz: Digital Health Accelerator des BIH begleitet Ausgründung der Aignostics GmbH

Aignostics schließt 5 Millionen Euro Seed-Finanzierung ab um KI-basierte Lösungen für die Pathologie voranzutreiben

„The DHA enabled us to turn our research results examining AI-based cancer diagnostics into practical applications. Not only did we have the chance to develop a software that is currently tested live, but we were also exposed to the business, regulatory, and legal aspects of our project. Learning these challenging skills put us in the position to pursue a stringent development path towards launching a spin-off company in the near future. I highly recommend the DHA to fellow researchers and clinicians looking to generate digital health innovations for better patient health outcomes.“

– Prof. Frederick Klauschen, project lead, 2019

"Over the last two years, the Digital Health Accelerator Program has helped us translate research results into a striving spin-off project. The BIH-DHA team was instrumental in helping us build our first prototypes within the Charité, in navigating the complex legal and regulatory aspects of AI in healthcare, and in putting together a strong cross-functional team. Even after concluding the program, we are still in close contact with the BIH and hope to see many more projects join the BIH family."

– Viktor Matyas, CEO, and Maximilian Alber, CTO, AIgnostics, 2020

KI gegen Karies: BIH Digital Health Accelerator begleitet Ausgründung des Start-ups dentalXrai

"The DHA was a great opportunity for us. It allowed us to not only develop a strong team using the flexible financial support provided, but also to grow into a start-up, building the mindset and the network. We would not have reached our current status without this support. We can highly recommend the program!"

– Prof. Falk Schwendicke and Dr. Joachim Krois, project leads, 2020

Ein digitales Gesundheitsportemonnaie für Menschen ohne Krankenversicherung

"For mTOMADY, the flexibility and willingness of the DHA to adapt to the needs and requirements of each individual team is the greatest strength of this program. It is not a one-size-fits-all approach. Instead, each team receives the support required to take the next step. This tailored approach has helped us meet the challenges we've been faced with, and overcome them as a stronger unit. It's been invaluable to our journey that started as an idea, grew into a small project in Madagascar, and has finally taken us to where we are today - an independent social enterprise dedicated to accelerating progress toward universal health coverage through innovation.“

– Dr. Julius Emmrich and Dr. Samuel Knauß, project leads, 2021

Neue Charité-Ausgründung Nephrolytix GmbH will akute Nierenschädigung zehnmal schneller erkennen

„Unsere Innovation wurde geboren als Folge eines klinischen Bedarfs, den wir als Nephrologen der Charité täglich erfahren. Sie basiert auf jahrelanger Forschungstätigkeit, deren Ergebnisse erfolgreich in die Charité-Ausgründung Nephrolytix überführt werden konnten. Diesen Forschungstransfer hat erst das BIH mit seinem Digital Health Accelerator Programm ermöglicht.“

Prof. Markus van der Giet, Chief Medical Officer und Mit-Gründer der Nephrolytix, 2022.

 

Frühwarnsystem für die Intensivstation

"The Digital Health Accelerator program accompanied our project from inception in 2017 to spin-off formation in late 2020. In the program, not only did we receive funding and guidance in developing an AI-driven product but the DHA team also helped us assemble a fantastic founding team. We believe that X-Cardiac has the potential to substantially increase patient benefit in intensive care units worldwide and would like to thank the DHA team for their dedicated support along our development path from research project to company."

– PD Dr. med. Alexander Meyer, project lead, 2021